The Metabolic Factor Kynurenic Acid of Kynurenine Pathway Predicts Major Depressive Disorder
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Metabolic Factor Kynurenic Acid of Kynurenine Pathway Predicts Major Depressive Disorder
Authors
Keywords
-
Journal
Frontiers in Psychiatry
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-11-19
DOI
10.3389/fpsyt.2018.00552
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The association between the hypothalamic pituitary adrenal axis and tryptophan metabolism in persons with recurrent major depressive disorder and healthy controls
- (2017) F.J.H. Sorgdrager et al. JOURNAL OF AFFECTIVE DISORDERS
- Epidemiology of Major Depressive Disorder Disability in the US Military
- (2017) Elizabeth R. Packnett et al. JOURNAL OF NERVOUS AND MENTAL DISEASE
- The kynurenine pathway in schizophrenia and bipolar disorder
- (2017) Sophie Erhardt et al. NEUROPHARMACOLOGY
- OXIDATIVE AND NITROSATIVE STRESS AS WELL AS THE TRYPTOPHAN CATABOLITES PATHWAY IN DEPRESSIVE DISORDERS
- (2017) Paulina Wigner et al. Psychiatria Danubina
- Duration of untreated bipolar disorder: a multicenter study
- (2017) Ling Zhang et al. Scientific Reports
- Disease-Induced Neuroinflammation and Depression
- (2016) Cristina Benatti et al. CNS & Neurological Disorders-Drug Targets
- Prevalence and correlates of major depressive disorder (MDD) among adolescent patients with epilepsy attending a Nigerian neuropsychiatric hospital
- (2016) Ayodele Fela-Thomas et al. EPILEPSY & BEHAVIOR
- Mast cells' involvement in inflammation pathways linked to depression: evidence in mastocytosis
- (2016) S Georgin-Lavialle et al. MOLECULAR PSYCHIATRY
- The inflammatory cytokines: molecular biomarkers for major depressive disorder?
- (2015) Charlotte Martin et al. Biomarkers in Medicine
- Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder
- (2015) Jonathan Savitz et al. BRAIN BEHAVIOR AND IMMUNITY
- Mood symptoms correlate with kynurenine pathway metabolites following sports-related concussion
- (2015) Rashmi Singh et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: Evidences from animal and human studies
- (2015) Gislaine Z. Réus et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder
- (2015) Jonathan Savitz et al. PSYCHONEUROENDOCRINOLOGY
- Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors
- (2015) Michael Platten et al. Frontiers in Immunology
- Putative Neuroprotective and Neurotoxic Kynurenine Pathway Metabolites Are Associated with Hippocampal and Amygdalar Volumes in Subjects with Major Depressive Disorder
- (2014) Jonathan Savitz et al. NEUROPSYCHOPHARMACOLOGY
- Substrate product ratios of enzymes in the kynurenine pathway measured in plasma as indicators of functional vitamin B-6 status
- (2013) Arve Ulvik et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Intracerebroventricular administration of lipopolysaccharide induces indoleamine-2,3-dioxygenase-dependent depression-like behaviors
- (2013) Marcus A Lawson et al. Journal of Neuroinflammation
- Activation of kynurenine pathway in ex vivo fibroblasts from patients with bipolar disorder or schizophrenia: Cytokine challenge increases production of 3-hydroxykynurenine
- (2013) Anne-Sofie Johansson et al. JOURNAL OF PSYCHIATRIC RESEARCH
- The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1 and with increased CSF KYNA level and reduced KMO expression
- (2013) C Lavebratt et al. MOLECULAR PSYCHIATRY
- NMDA Receptor Blockade by Ketamine Abrogates Lipopolysaccharide-Induced Depressive-Like Behavior in C57BL/6J Mice
- (2013) Adam K Walker et al. NEUROPSYCHOPHARMACOLOGY
- Monoamine neurocircuitry in depression and strategies for new treatments
- (2013) Michel Hamon et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- 3-Hydroxykynurenine: An intriguing molecule exerting dual actions in the Central Nervous System
- (2012) Ana Laura Colín-González et al. NEUROTOXICOLOGY
- Major depressive disorder: new clinical, neurobiological, and treatment perspectives
- (2011) David J Kupfer et al. LANCET
- Biomarkers for major depression and its delineation from neurodegenerative disorders
- (2011) Barbara Schneider et al. PROGRESS IN NEUROBIOLOGY
- Inflammatory Biomarkers in Depression: An Opportunity for Novel Therapeutic Interventions
- (2011) Madeline Li et al. Current Psychiatry Reports
- Localization of Dysfunction in Major Depressive Disorder: Prefrontal Cortex and Amygdala
- (2010) Elisabeth A. Murray et al. BIOLOGICAL PSYCHIATRY
- Manic-Depressive Illness
- (2009) David J. Lynn JOURNAL OF CLINICAL PSYCHIATRY
- Induction of IDO by Bacille Calmette-Guerin Is Responsible for Development of Murine Depressive-Like Behavior
- (2009) J. C. O'Connor et al. JOURNAL OF IMMUNOLOGY
- CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-α: relationship to CNS immune responses and depression
- (2009) C L Raison et al. MOLECULAR PSYCHIATRY
- Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway
- (2008) Helen J. Ball et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice
- (2008) J C O'Connor et al. MOLECULAR PSYCHIATRY
- From inflammation to sickness and depression: when the immune system subjugates the brain
- (2007) Robert Dantzer et al. NATURE REVIEWS NEUROSCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started